NASDAQ · WENA
Healthcare · Biotechnology
$0.73
Down-$0.03 (-3.84%)
Updated Aug 14, 2026, 6:30 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
WENA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning WENA.
WENA research
Company profile and research snapshot.
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Aug 19, 2024
ANEW MEDICAL, INC. announced the appointment of Jeffrey LeBlanc as the company's Chief Financial Officer, replacing the interim CFO, Edward Cong Wang. LeBlanc has over 20 years of experience in managing financial operations and launching new ventures.
GlobeNewswire Inc. · Aug 15, 2024
ANEW MEDICAL, INC. announced the grant and issuance of a U.S. patent covering the secreted RNA splice variant of the human Klotho gene, which is used for the treatment of cognitive and neurodegenerative diseases. This patent provides ANEW with protection for the development and commercialization of its innovative protein, cell, and gene therapies in the U.S.
Benzinga · Jul 9, 2024
ANEW Medical, Inc. (WENA) saw its shares surge nearly 80% in pre-market trading after announcing the advancement of its patented Klotho gene therapy program for neurodegenerative disorders like ALS, Alzheimer's, and Parkinson's disease.
PennyStocks · Jun 27, 2024
Here's some quick tips on buying energy penny stocks in 2024 The post Buying Energy Penny Stocks? Use These 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning WENA.
No results
No recent SID articles mention WENA.
